CN107916291A - lncRNA组合物及制备诊断预示三阴性型乳腺癌骨转移试剂盒的用途 - Google Patents
lncRNA组合物及制备诊断预示三阴性型乳腺癌骨转移试剂盒的用途 Download PDFInfo
- Publication number
- CN107916291A CN107916291A CN201711142801.1A CN201711142801A CN107916291A CN 107916291 A CN107916291 A CN 107916291A CN 201711142801 A CN201711142801 A CN 201711142801A CN 107916291 A CN107916291 A CN 107916291A
- Authority
- CN
- China
- Prior art keywords
- lncrna
- bone
- breast cancer
- qpcr
- indication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010006187 Breast cancer Diseases 0.000 title claims abstract description 178
- 208000026310 Breast neoplasm Diseases 0.000 title claims abstract description 177
- 238000003745 diagnosis Methods 0.000 title claims abstract description 82
- 206010005949 Bone cancer Diseases 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 108091046869 Telomeric non-coding RNA Proteins 0.000 title description 22
- 108020005198 Long Noncoding RNA Proteins 0.000 claims abstract description 228
- 210000002966 serum Anatomy 0.000 claims abstract description 50
- 108091007417 HOX transcript antisense RNA Proteins 0.000 claims abstract description 30
- 238000011529 RT qPCR Methods 0.000 claims description 97
- 230000014509 gene expression Effects 0.000 claims description 72
- 238000009007 Diagnostic Kit Methods 0.000 claims description 41
- 230000000692 anti-sense effect Effects 0.000 claims description 30
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 23
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 238000007477 logistic regression Methods 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 7
- 230000015271 coagulation Effects 0.000 claims description 6
- 238000005345 coagulation Methods 0.000 claims description 6
- 210000003462 vein Anatomy 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 210000000988 bone and bone Anatomy 0.000 abstract description 85
- 238000012546 transfer Methods 0.000 abstract description 83
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 abstract description 34
- 208000026535 luminal A breast carcinoma Diseases 0.000 abstract description 33
- 238000012360 testing method Methods 0.000 abstract description 33
- 230000002018 overexpression Effects 0.000 abstract description 32
- 102100039540 Exocyst complex component 7 Human genes 0.000 abstract description 26
- 101000813489 Homo sapiens Exocyst complex component 7 Proteins 0.000 abstract description 26
- 238000002360 preparation method Methods 0.000 abstract description 2
- 102100027341 Neutral and basic amino acid transport protein rBAT Human genes 0.000 abstract 1
- 101710159376 Neutral and basic amino acid transport protein rBAT Proteins 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 description 52
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 28
- 108020004414 DNA Proteins 0.000 description 20
- 238000012795 verification Methods 0.000 description 20
- 238000011156 evaluation Methods 0.000 description 16
- 238000011144 upstream manufacturing Methods 0.000 description 15
- 239000012141 concentrate Substances 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 12
- 230000004069 differentiation Effects 0.000 description 10
- 238000013211 curve analysis Methods 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 206010027476 Metastases Diseases 0.000 description 7
- 238000002591 computed tomography Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 239000012807 PCR reagent Substances 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000013480 data collection Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000009401 metastasis Effects 0.000 description 4
- 108091027963 non-coding RNA Proteins 0.000 description 4
- 102000042567 non-coding RNA Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 238000012109 statistical procedure Methods 0.000 description 4
- 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000022679 triple-negative breast carcinoma Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- -1 ER) Proteins 0.000 description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
- 240000002825 Solanum vestissimum Species 0.000 description 2
- 235000018259 Solanum vestissimum Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000007469 bone scintigraphy Methods 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 102000015694 estrogen receptors Human genes 0.000 description 2
- 108010038795 estrogen receptors Proteins 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 102000003998 progesterone receptors Human genes 0.000 description 2
- 108090000468 progesterone receptors Proteins 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 241000023308 Acca Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 206010055113 Breast cancer metastatic Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006718 epigenetic regulation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000027706 hormone receptor-positive breast cancer Diseases 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000025915 regulation of apoptotic process Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711142801.1A CN107916291B (zh) | 2017-11-17 | 2017-11-17 | 一种用于诊断预示三阴性型乳腺癌骨转移的基因诊断试剂盒 |
PCT/CN2018/072269 WO2019095541A1 (zh) | 2017-11-17 | 2018-01-11 | 一种诊断预示乳腺癌骨转移的组合物及诊断预示方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711142801.1A CN107916291B (zh) | 2017-11-17 | 2017-11-17 | 一种用于诊断预示三阴性型乳腺癌骨转移的基因诊断试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107916291A true CN107916291A (zh) | 2018-04-17 |
CN107916291B CN107916291B (zh) | 2019-01-08 |
Family
ID=61896542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711142801.1A Active CN107916291B (zh) | 2017-11-17 | 2017-11-17 | 一种用于诊断预示三阴性型乳腺癌骨转移的基因诊断试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107916291B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109825592A (zh) * | 2019-04-15 | 2019-05-31 | 德阳市人民医院 | 一种与乳腺癌发生发展相关的生物标志物的用途 |
CN111214482A (zh) * | 2020-02-21 | 2020-06-02 | 东莞市第八人民医院(东莞市儿童医院) | 一种靶向linc00467基因的siRNA在白血病耐药性中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104971363A (zh) * | 2015-05-22 | 2015-10-14 | 浙江大学 | 靶向抑制hotair的小rna在制备抗前列腺癌药物中的应用 |
CN105316402A (zh) * | 2015-04-02 | 2016-02-10 | 复旦大学附属肿瘤医院 | 一种预测三阴性乳腺癌预后及化疗敏感性的mRNA联合lncRNA模型及应用 |
CN105586399A (zh) * | 2015-09-07 | 2016-05-18 | 张国新 | 一种与胃癌相关的血清/血浆lncRNA标志物试剂盒 |
-
2017
- 2017-11-17 CN CN201711142801.1A patent/CN107916291B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105316402A (zh) * | 2015-04-02 | 2016-02-10 | 复旦大学附属肿瘤医院 | 一种预测三阴性乳腺癌预后及化疗敏感性的mRNA联合lncRNA模型及应用 |
CN104971363A (zh) * | 2015-05-22 | 2015-10-14 | 浙江大学 | 靶向抑制hotair的小rna在制备抗前列腺癌药物中的应用 |
CN105586399A (zh) * | 2015-09-07 | 2016-05-18 | 张国新 | 一种与胃癌相关的血清/血浆lncRNA标志物试剂盒 |
Non-Patent Citations (4)
Title |
---|
ALDEMA SAS-CHEN, ET AL.: "LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer", 《EMBO MOLECULAR MEDICINE》 * |
RAJNISH A. GUPTA, ET AL.: "Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis", 《NATURE》 * |
YUAN-LIANG WANG, ET AL.: "Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR", 《ONCOTARGET》 * |
朱玉翠 等: "长链非编码RNA在乳腺癌中的研究进展", 《临床检验杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109825592A (zh) * | 2019-04-15 | 2019-05-31 | 德阳市人民医院 | 一种与乳腺癌发生发展相关的生物标志物的用途 |
CN111214482A (zh) * | 2020-02-21 | 2020-06-02 | 东莞市第八人民医院(东莞市儿童医院) | 一种靶向linc00467基因的siRNA在白血病耐药性中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN107916291B (zh) | 2019-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110484624B (zh) | 一种基于外周血的胃癌生物标志物及其检测方法和应用 | |
CN105603101B (zh) | 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 | |
CN102534008B (zh) | 一种与非贲门癌辅助诊断相关的snp标志物及其应用 | |
Qiu et al. | Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study | |
CN102534009B (zh) | 一种与原发性肺癌辅助诊断相关的snp标志物及其应用 | |
CN107881239A (zh) | 血浆中与结直肠癌转移相关的miRNA标志物及其应用 | |
CN107746887B (zh) | lncRNA组合物及制备诊断预示Luminal A型乳腺癌骨转移基因诊断试剂盒的用途 | |
CN108531586A (zh) | 一种与乳腺癌辅助诊断相关的位于X染色体上的循环miRNA标志物及其应用 | |
CN107916291B (zh) | 一种用于诊断预示三阴性型乳腺癌骨转移的基因诊断试剂盒 | |
CN104818322B (zh) | miRNA和Cyfra21‑1联合在检测非小细胞肺癌中的应用 | |
CN102925444A (zh) | 膀胱癌的血清miRNA生物标志物及其表达量检测方法 | |
CN107746888B (zh) | 一种用于诊断预示Her-2过表达型乳腺癌骨转移的基因诊断试剂盒 | |
CN106636440B (zh) | 血浆microRNAs用于制备筛查诊断男性群体中肺腺癌患者的诊断试剂的用途 | |
CN107699619B (zh) | lncRNA组合物及制备诊断预示Luminal B型乳腺癌骨转移基因诊断试剂盒的用途 | |
CN107904309B (zh) | 一种用于诊断预示三阴性型乳腺癌骨转移的基因诊断试剂盒 | |
CN108424962A (zh) | 系膜增生性肾小球肾炎的miRNA检测标志物及其诊断试剂盒 | |
CN105087758A (zh) | 一种肺癌预后预测miRNA检测试剂盒 | |
CN108165546A (zh) | 一种miRNA生物标志物、组合物及其用途 | |
CN110257514A (zh) | 一种新的食管癌血液miRNA标志物及其应用 | |
WO2019095541A1 (zh) | 一种诊断预示乳腺癌骨转移的组合物及诊断预示方法 | |
CN107858430B (zh) | 一种用于诊断预示Her-2过表达型乳腺癌骨转移的基因诊断试剂盒 | |
CN107881235B (zh) | 一种用于诊断预示Luminal A型乳腺癌骨转移的基因诊断试剂盒 | |
CN107699620B (zh) | 一种用于诊断预示Luminal B型乳腺癌骨转移的基因诊断试剂盒 | |
CN104878012B (zh) | Hsa‑miR‑3200‑5p在制备早期筛查或诊断Brachyury阳性肿瘤试剂或试剂盒中的应用 | |
CN104774916B (zh) | 一种用于检测转移性结直肠癌化疗疗效和/或预后的生物标志物组合及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181120 Address after: Room 501, Building A11, Beihu Science and Technology Park, 3333 Shengbei Street, Beihu Science and Technology Development Zone, Changchun City, Jilin Province, 130000 Applicant after: Jilin Huahui Biotechnology Co.,Ltd. Address before: 226019 Nantong University, Nantong City, Jiangsu, No. 9, Nantong University Applicant before: Li Yijian |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200509 Address after: 266000, No. 1, 2, building 7, Qingdao blue bio Pharmaceutical Industrial Park, 368 Hedong Road, Hedong District, Qingdao, Shandong Patentee after: QINGDAO RESTORE BIOTECHNOLOGY Co.,Ltd. Address before: 130000 North Lake Science and Technology Development Zone, Changchun, Jilin, China, 501 A11, North Lake Science and Technology Park, 3333 Shengbei street. Patentee before: Jilin Huahui Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200619 Address after: 266000 3rd floor, building 7, Qingdao blue biomedical industrial park, 368 Hedong Road, high tech Zone, Qingdao, Shandong Province Patentee after: Qingdao Ruisi de medical laboratory Co.,Ltd. Address before: 266000, No. 1, 2, building 7, Qingdao blue bio Pharmaceutical Industrial Park, 368 Hedong Road, Hedong District, Qingdao, Shandong Patentee before: QINGDAO RESTORE BIOTECHNOLOGY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A gene diagnostic kit for diagnosing and predicting triple-negative breast cancer bone metastasis Effective date of registration: 20220804 Granted publication date: 20190108 Pledgee: Beijing Bank Co.,Ltd. Qingdao Branch Pledgor: Qingdao Ruisi de medical laboratory Co.,Ltd. Registration number: Y2022370010123 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220819 Granted publication date: 20190108 Pledgee: Beijing Bank Co.,Ltd. Qingdao Branch Pledgor: Qingdao Ruisi de medical laboratory Co.,Ltd. Registration number: Y2022370010123 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A gene diagnostic kit for diagnosing and predicting triple-negative breast cancer bone metastasis Effective date of registration: 20220822 Granted publication date: 20190108 Pledgee: Beijing Bank Co.,Ltd. Qingdao Branch Pledgor: Qingdao Ruisi de medical laboratory Co.,Ltd. Registration number: Y2022370010130 |